Ross Douglas T. 4
4 · Oncocyte Corp · Filed Dec 20, 2022
Insider Transaction Report
Form 4
Transactions
- Disposition to Issuer
Common Stock, no par value
2022-12-01−150,000→ 20,317 total - Disposition to Issuer
Option to Purchase Common Stock
2022-12-16−83,334→ 166,666 totalExercise: $1.93→ Common Stock (83,334 underlying) - Disposition to Issuer
Option to Purchase Common Stock
2022-12-16−100,000→ 0 totalExercise: $1.15→ Common Stock (100,000 underlying) - Disposition to Issuer
Option to Purchase Common Stock
2022-12-16−143,438→ 111,562 totalExercise: $5.34→ Common Stock (143,438 underlying) - Disposition to Issuer
Option to Purchase Common Stock
2022-12-16−100,000→ 0 totalExercise: $1.15→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]The restricted stock units were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 16, 2022. Any remaining restricted stock units immediately vested on December 16, 2022.
- [F2]The options were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 16, 2022. Any remaining options immediately vested and became exercisable as of December 16, 2022.